AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2020
Nov 13, 2020
30718_dirs_2020-11-13_5cd63f73-d31e-4ef9-9057-8506f0ee31e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-11-09
Reporting Person: Hippel James (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-11 | Stock Option (Right to Buy) | $106.59 | M | 7391 | Disposed | 2023-08-18 | Common Stock (7391) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9137 | Direct |
Footnotes
F1: Fully exercisable.
F2: This amendment is being filed solely to correct a typographical error in the number of shares exercised.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4